ASA: Proposed Nerve Block LCD “Inconsistent With Best Practices”

The American Society of Anesthesiologists laid out concerns last Friday over the language in a proposed Local Coverage Determination DL33188 on Nerve Blockades from Noridan Healthcare Solutions  

Advertisement

 
A statement from the ASA on their website noted that the LCD had contradictory language as well as content that the ASA believes takes the focus of care away from the patient.
 
Additionally, the ASA requested a full explanation for the reasoning behind the proposed documentation requirements for the LCD and an example of the correct protocol for completing documentation.  
 

More Articles on Anesthesia:

Congress Looks at GR Repeal, Must Also Tackle Anesthesiologists’ 33% Problem Prior

Survey: Pulse Oximetry Sensor Oxygen Reading Troubles Plague 53% Anesthesiologists

ASA Supports Congress in Expanding HIT Hardship Exemptions for Anesthesiologists

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.